updated 5/10/2010 1:36:03 PM ET 2010-05-10T17:36:03

Biopharmaceutical company Progenics Pharmaceuticals Inc. said Monday its first-quarter loss widened, as research and development revenue sank compared to last year, when the company also received a $15 million payment.

The Tarrytown, N.Y., company said it lost $18.6 million, or 58 cents per share, in the three months that ended March 31. That compares to a loss of $1.8 million, or 6 cents per share, in the first quarter of 2009.

First-quarter revenue dropped to $1.5 million from $20.9 million.

Analysts expected a loss of 41 cents per share on nearly $6 million in revenue, according to a survey by Thomson Reuters.

The company attributed part of its revenue decline to the end of a collaboration with Wyeth, which was purchased by Pfizer Inc. last year. Progenics also recorded a $15-million payment from Ono Pharmaceutical Co. Ltd. in the first quarter of 2009.

Progenics said worldwide sales of the drug Relistor grew 6 percent to $4.2 million in the first quarter. Relistor is designed to treat constipation caused by use of opioid painkillers, which is a common side effect of treatment with those drugs.

The company's expenses also fell 14 percent in the first quarter to $20.1 million, due mainly to lower compensation expenses from a headcount reduction. Research and development expenses fell 20 percent to $11.9 million.

Shares of Progenics fell 10 cents to $5.43 in afternoon trading Monday.

Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 2.48%
$30K home equity loan FICO 5.80%
$75K home equity loan FICO 4.54%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.57%
13.57%
Cash Back Cards 17.91%
17.91%
Rewards Cards 17.15%
17.15%
Source: Bankrate.com